个体黄酸盐摄入量及其与美国成年人高血压的关联:基于人口的横截面研究
Feier Wu1, Yilin Wu2, Qiuyun Chen1
1Department of Cardiology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, Jiangsu Province, China.
Medicine
|November 8, 2025
概括
更高的摄入特定的食类黄素,如奎尔丁和甲素可能会降低高血压的风险. 这些化合物存在于许多食物中,显示出对高血压的保护作用.
科学领域:
- 营养流行病学 营养流行病学
- 心血管健康 心血管健康
- 饮食中的生物活性.
背景情况:
- 高血压 (HTN) 是一个重大的全球健康挑战.
- 饮食中的黄类药物提供潜在的健康益处,但它们对HTN风险的具体影响需要进一步调查.
- 有限的流行病学数据存在于个人黄类消费和高血压发病率.
研究的目的:
- 为了研究个人黄类素摄入量与高血压风险之间的关联.
- 确定可能提供对高血压的保护的特定黄类和子类.
- 探索黄类药物与高血压风险之间的剂量反应关系和可变重要性.
主要方法:
- 利用来自国家健康和营养检查调查 (NHANES) 的数据来查看人口特征和疾病数据.
- 采用多变量逻辑回归和通用添加模型来分析黄类素摄入量和HTN风险.
- 通过机器学习模型进行了沙普利增量解释 (SHAP) 分析,以确定变量的重要性.
主要成果:
- 增加单个黄类药物的摄入量 (quercetin,epicatechin,naringenin) 和子类 (flavanones,flavonols) 与降低高血压风险有关.
- 奎尔塞丁和纳灵宁被机器学习模型确定为最具影响力的单个黄类.
- 观察到flavanones和naringenin的线性负相关性,而发现了Quercetin,Epicatechin和flavones的非线性关系.
结论:
- 摄入富含特定类黄的食物,特别是素,甲素和甲素,可能有助于预防和管理高血压.
- 这些发现表明,一种潜在的饮食策略可以减少人口的心血管疾病负担.
- 需要进一步研究这些黄胺在心血管健康中的特定机制.
更多相关视频
相关概念视频
Cancer Prevention
7.6K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
7.6K
Hypertension III: Clinical Manifestations and Diagnostic Studies
452
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
452
Hypertension and Regulation of Blood Pressure
3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension I: Introduction
721
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
721
Hypertension II: Pathophysiology
765
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
765
Hypertension IV: Drug Therapy and Lifestyle Modifications
600
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
600


